Cargando…

Reactive arthritis after SARS-CoV-2 infection

SARS-CoV-2 has been recognised as a potential trigger of inflammatory arthritis in individuals with inflammatory rheumatic diseases as well as in previously unaffected individuals. However, new-onset arthritis after COVID-19 is a heterogeneous phenomenon that complicates differential diagnosis. For...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dombret, Sophia, Skapenko, Alla, Schulze-Koops, Hendrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471204/ https://www.ncbi.nlm.nih.gov/pubmed/36096524 http://dx.doi.org/10.1136/rmdopen-2022-002519

Ejemplares similares

Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines
por: Schulze-Koops, Hendrik, et al.
Publicado: (2021)

Regulatory T cells in rheumatoid arthritis
por: Leipe, Jan, et al.
Publicado: (2005)

TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD
por: Regierer, Anne Constanze, et al.
Publicado: (2021)

Biosimilars in rheumatology: A review of the evidence and their place in the treatment algorithm
por: Schulze-Koops, Hendrik, et al.
Publicado: (2017)

COVID-19 vaccination in individuals with inflammatory rheumatic diseases
por: Skapenko, Alla, et al.
Publicado: (2022)

IFNGR1 single nucleotide polymorphisms in rheumatoid arthritis
por: Mattyasovszky, Stefan, et al.
Publicado: (2006)

Altered T Cell Differentiation in Patients with Early Rheumatoid Arthritis
por: Skapenko, Alla, et al.
Publicado: (2000)

Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases
por: Hasseli, Rebecca, et al.
Publicado: (2023)

Spontaneous abortion as differential diagnosis of intermittent glomerular proteinuria in inactive systemic lupus erythematosus
por: Ullrich, Fabian T. H., et al.
Publicado: (2023)

Reactive arthritis after SARS-CoV-2 infection
por: Sureja, Nayan Patel, et al.
Publicado: (2021)

Cytokine mRNA and protein expression in primary-culture and repeated-passage synovial fibroblasts from patients with rheumatoid arthritis
por: Hirth, Astrid, et al.
Publicado: (2002)

A rare side effect of methotrexate therapy: drug-induced osteopathy with multiple fractures of the lower limb
por: Singh, Delila, et al.
Publicado: (2023)

Analysis of the Transcriptional Program of Developing Induced Regulatory T Cells
por: Prots, Iryna, et al.
Publicado: (2011)

The role of the T cell in autoimmune inflammation
por: Skapenko, Alla, et al.
Publicado: (2005)

Arthritis after SARS-CoV-2 infection: reactive arthritis or virally mediated arthritis?
por: Baimukhamedov, Chokan, et al.
Publicado: (2022)

Risk factors for and pregnancy outcomes after SARS‐CoV‐2 in pregnancy according to disease severity: A nationwide cohort study with validation of the SARS‐CoV‐2 diagnosis
por: Aabakke, Anna J. M., et al.
Publicado: (2023)

Aktueller Stand der Impfung gegen SARS-CoV-2
por: Iking-Konert, Christof, et al.
Publicado: (2021)

Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors
por: Venerito, Vincenzo, et al.
Publicado: (2022)

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
por: Haveri, Anu, et al.
Publicado: (2021)

Fibrin microthrombi in bladder urothelium after SARS-CoV-2 infection: Case report
por: Hoang Roberts, Ly, et al.
Publicado: (2023)

SARS‐CoV‐2 infection in pregnancy in Denmark—characteristics and outcomes after confirmed infection in pregnancy: A nationwide, prospective, population‐based cohort study
por: Aabakke, Anna J. M., et al.
Publicado: (2021)

Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipients
por: Hagemann, Kerri, et al.
Publicado: (2022)

Atypical presentation of SARS-CoV-2 infection in male genitalia
por: Özveri, Hakan, et al.
Publicado: (2020)

Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection
por: Canto e Castro, Luísa, et al.
Publicado: (2021)

Reactive Arthritis Post-SARS-CoV-2
por: Ouedraogo, Faizal, et al.
Publicado: (2021)

Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda
por: Kirenga, Bruce, et al.
Publicado: (2020)

Arthritis after SARS-CoV-2 infection
por: Baimukhamedov, Chokan, et al.
Publicado: (2021)

Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritis
por: Stahl, David, et al.
Publicado: (2022)

Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider
por: Alunno, Alessia, et al.
Publicado: (2021)

Characteristics and treatment of new-onset arthritis after checkpoint inhibitor therapy
por: Leipe, Jan, et al.
Publicado: (2018)

Distinct Metagenomic Signatures in the SARS-CoV-2 Infection
por: Liu, Yijun, et al.
Publicado: (2021)

The bias for Th1 cell differentiation of rheumatoid arthritis T cells is characteristic of memory but not of naive T cells
por: Skapenko, A, et al.
Publicado: (2002)

Update on Neurological Manifestations of SARS-CoV-2
por: Valiuddin, Hisham M., et al.
Publicado: (2020)

Endoscopic findings of laryngitis caused by SARS-CoV-2/Omicron variant infection
por: Nishiyama, Yuri, et al.
Publicado: (2022)

Acute testicular infarction in the setting of SARS-CoV-2 infection and diabetic vasculopathy
por: Zhang, Tenny R., et al.
Publicado: (2023)

SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry
por: Lawson-Tovey, Saskia, et al.
Publicado: (2022)

Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination
por: Johnson, Síle A, et al.
Publicado: (2023)

Can SARS-CoV-2 trigger reactive arthritis?
por: Wendling, Daniel, et al.
Publicado: (2021)

Neutralizing antibody responses 300 days after SARS‐CoV‐2 infection and induction of high antibody titers after vaccination
por: Urlaub, Doris, et al.
Publicado: (2022)

Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity
por: Hazan, Sabine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jregq9blt3c8u6p6o03rgolvgj